Pubblicazioni

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

2018 - FUTURE ONCOLOGY

Bracarda, S.; Galli, L.; Maruzzo, M.; Lo Re, G.; Buti, Sebastiano; Favaretto, A.; Di Costanzo, F.; Sacco, C.; Merlano, M.; Mucciarini, C.; Zafarana, E.; Romito, S.; Maestri, A.; Giorgio, C. G.; Ionta, M. T.; Turci, D.; De Giorgi, U.; Procopio, G.; Cortesi, E.; Giannarelli, D.; Porta, C.

A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimerâs disease and MCI patients: implications for regenerative medicine approaches

2017 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Morena, F.; Argentati, C.; Trotta, R.; Crispoltoni, L.; Stabile, A.; Pistilli, A.; di Baldassarre, A.; Calafiore, R.; Montanucci, P.; Basta, G.; Pedrinolla, A.; Smania, N.; Venturelli, M.; Schena, F.; Naro, F.; Emiliani, C.; Rende, M.; Martino, S.

Pubblicazioni

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimerâs disease and MCI patients: implications for regenerative medicine approaches

A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimerâs disease and MCI patients: implications for regenerative medicine approaches